Upfront therapy with allogeneic hematopoietic stem cell transplantation versus DNA methyltransferase inhibitors in patients with vexas syndrome: A comparative matched cohort efficacy analysis of 39 patientsSaubia Fathima, Abhishek A. Mangaonkar, Kimberly J. Langer et al.|Blood|2025Cited by 0